Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational medication designed to help reduce PTSD symptoms.
Post-Traumatic Stress Disorder (PTSD)
Age Range:
18
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This research study is evaluating TSND-201 (methylone), an investigational medication, to determine whether it may help improve symptoms of PTSD. Researchers will compare the study drug to placebo to assess its effectiveness, safety, and tolerability.
Qualifications
You may be able to join if you:
- Are 18 years of age or older.
- Have been diagnosed with PTSD for at least 6 months.
- Have moderate to severe PTSD symptoms.
- Have previously tried at least one PTSD treatment (medication or therapy).
- Are able to attend all study visits and follow study procedures.
- Are willing to stop certain medications that are not allowed during the study, if medically appropriate.
FEATURED STUDIES
Heart Disease & Inflammation Study
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase
Heart Failure Prevention Study
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Weight & Wellness Research Study Interest
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Flu Prevention Study Interest List
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
General Anxiety Disorder Study
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
Uncontrolled COPD Study
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a